Trustmark National Bank Trust Department Has $435,000 Stock Holdings in Centene Co. (NYSE:CNC)

Trustmark National Bank Trust Department decreased its holdings in shares of Centene Co. (NYSE:CNC) by 7.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,775 shares of the company’s stock after selling 494 shares during the period. Trustmark National Bank Trust Department’s holdings in Centene were worth $435,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Park Place Capital Corp grew its stake in shares of Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after acquiring an additional 357 shares in the last quarter. WR Wealth Planners LLC grew its stake in shares of Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc bought a new stake in shares of Centene in the 2nd quarter worth $33,000. Riverview Trust Co grew its position in Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after buying an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new position in Centene during the second quarter valued at about $36,000. Institutional investors own 93.63% of the company’s stock.

Centene Trading Up 2.0 %

Shares of CNC opened at $60.30 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Co. has a 1 year low of $57.20 and a 1 year high of $81.42. The company has a 50 day simple moving average of $66.98 and a two-hundred day simple moving average of $70.60. The firm has a market cap of $30.44 billion, a P/E ratio of 10.47, a price-to-earnings-growth ratio of 0.79 and a beta of 0.49.

Insider Activity

In other Centene news, CEO Sarah London bought 4,117 shares of Centene stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This trade represents a 0.62 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Andrew Lynn Asher bought 17,200 shares of Centene stock in a transaction on Wednesday, November 13th. The stock was acquired at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the purchase, the chief financial officer now owns 486,847 shares of the company’s stock, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

CNC has been the subject of several research reports. Oppenheimer reduced their price target on shares of Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, July 29th. Barclays dropped their price objective on shares of Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a report on Tuesday, October 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 price objective on shares of Centene in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Centene from $82.00 to $87.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Monday, October 28th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $83.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.